Anti-XPC/ RAD4/ XP3C monoclonal antibody

Anti-XPC/ RAD4/ XP3C antibody for FACS & in-vivo assay

Target products collectionGo to XPC/XPC products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2387-Ab-1/ GM-Tg-hg-MP2387-Ab-2Anti-Human XPC monoclonal antibodyHuman
GM-Tg-rg-MP2387-Ab-1/ GM-Tg-rg-MP2387-Ab-2Anti-Rat XPC monoclonal antibodyRat
GM-Tg-mg-MP2387-Ab-1/ GM-Tg-mg-MP2387-Ab-2Anti-Mouse XPC monoclonal antibodyMouse
GM-Tg-cynog-MP2387-Ab-1/ GM-Tg-cynog-MP2387-Ab-2Anti-Cynomolgus/ Rhesus macaque XPC monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2387-Ab-1/ GM-Tg-felg-MP2387-Ab-2Anti-Feline XPC monoclonal antibodyFeline
GM-Tg-cang-MP2387-Ab-1/ GM-Tg-cang-MP2387-Ab-2Anti-Canine XPC monoclonal antibodyCanine
GM-Tg-bovg-MP2387-Ab-1/ GM-Tg-bovg-MP2387-Ab-2Anti-Bovine XPC monoclonal antibodyBovine
GM-Tg-equg-MP2387-Ab-1/ GM-Tg-equg-MP2387-Ab-2Anti-Equine XPC monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2387-Ab-1/ GM-Tg-hg-MP2387-Ab-2; GM-Tg-rg-MP2387-Ab-1/ GM-Tg-rg-MP2387-Ab-2;
GM-Tg-mg-MP2387-Ab-1/ GM-Tg-mg-MP2387-Ab-2; GM-Tg-cynog-MP2387-Ab-1/ GM-Tg-cynog-MP2387-Ab-2;
GM-Tg-felg-MP2387-Ab-1/ GM-Tg-felg-MP2387-Ab-2; GM-Tg-cang-MP2387-Ab-1/ GM-Tg-cang-MP2387-Ab-2;
GM-Tg-bovg-MP2387-Ab-1/ GM-Tg-bovg-MP2387-Ab-2; GM-Tg-equg-MP2387-Ab-1/ GM-Tg-equg-MP2387-Ab-2
Products NameAnti-XPC monoclonal antibody
Formatmab
Target NameXPC
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-XPC benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species XPC/ RAD4/ XP3C VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP2387
    Target NameXPC
    Gene ID7508,22591,312560,700938,476521,101080440,524274,100050424
    Gene Symbol and Synonymsp125,RAD4,XP3,XPC,XPCC
    Uniprot AccessionQ01831
    Uniprot Entry NameXPC_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000154767
    Target ClassificationTumor-associated antigen (TAA)

    The target: XPC, gene name: XPC, also named as RAD4, XP3C, p125, XPC. The protein encoded by this gene is a key component of the XPC complex, which plays an important role in the early steps of global genome nucleotide excision repair (NER). The encoded protein is important for damage sensing and DNA binding, and shows a preference for single-stranded DNA. Mutations in this gene or some other NER components can result in Xeroderma pigmentosum, a rare autosomal recessive disorder characterized by increased sensitivity to sunlight with the development of carcinomas at an early age. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.